Porphyria cutanea tarda - When skin meets liver

Best Practice and Research: Clinical Gastroenterology

Volumn 24, Issue 5, 2010, Pages 735-745

  Frank, Jorge ^a   Poblete Gutiérrez, Pamela ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Heme biosynthesis; Porphyria; Porphyria cutanea tarda; Uroporphyrinogen decarboxylase

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CHLOROQUINE; ESTROGEN; FERRITIN; HEXACHLOROBENZENE; HOMODIMER; IRON; ISOCOPROPORPHYRIN; KETOPROFEN; NABUMETONE; NALIDIXIC ACID; NAPROXEN; ORAL CONTRACEPTIVE AGENT; PORPHYRIN; RETINOID; SUNSCREEN; TETRACYCLINE; UNCLASSIFIED DRUG; UROPORPHYRIN; UROPORPHYRINOGEN DECARBOXYLASE;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALOPECIA; BIOSYNTHESIS; BLISTER; CONGENITAL ERYTHROPOIETIC PORPHYRIA; COPROPORPHYRIA; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISORDERS OF PORPHYRIN AND HEME METABOLISM; ENZYME ACTIVITY; ENZYME DEFECT; EROSION; ERYTHROCYTE; ERYTHROPOIESIS; ESTROGEN THERAPY; EXON; FECES ANALYSIS; FERRITIN BLOOD LEVEL; GENE MAPPING; GENE MUTATION; GENETIC DISORDER; GENETIC HETEROGENEITY; HEMOCHROMATOSIS; HEPATITIS C VIRUS; HEPATOERYTHROPOIETIC PORPHYRIA; HUMAN; HYPERPIGMENTATION; HYPERTRICHOSIS; INCIDENCE; INGESTION; IRON BLOOD LEVEL; IRON OVERLOAD; LIVER CIRRHOSIS; LIVER DISEASE; LIVER HEMOSIDEROSIS; ONSET AGE; PATHOPHYSIOLOGY; PHLEBOTOMIST; PHOTOSENSITIVITY; PORPHYRIA CUTANEA TARDA; PORPHYRIA VARIEGATA; PREVALENCE; PROMOTER REGION; PROTECTIVE CLOTHING; PSEUDOPORPHYRIA CUTANEA TARDA; REMISSION; REVIEW; SCAR FORMATION; SCLERODERMA; SCLERODERMOID PLAQUE; SEX RATIO; SKIN FRAGILITY; SKIN MANIFESTATION; SUN EXPOSURE; TREATMENT DURATION; TYPE I PORPHYRIA CUTANEA TARDA; TYPE II PORPHYRIA CUTANEA TARDA; URINALYSIS; URINARY EXCRETION; URINE COLOR;

EID: 77958109011     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2010.07.002     Document Type: Article

References (62)

1. H. Puy, L. Gouya, and J.C. Deybach Porphyrias Lancet 375 2010 924 937
2. D.R. Bickers, and J. Frank The porphyrias K. Wolff, L.A. Goldsmith, S.I. Katz, B.A. Gilchrest, A. Paller, D.J. Leffell, Fitzpatrick's dermatology in general medicine 2007 McGraw Hill 1228 1256
3. J. Waldenström Studien über porphyrie Acta Med Scand Suppl 82 1937 1 24
4. R.W. Lambrecht, M. Thapar, and H.L. Bonkovsky Genetic aspects of porphyria cutanea tarda Semin Liver Dis 27 2007 99 108
5. G.H. Elder The cutaneous porphyrias Semin Dermatol 9 1990 63 69
6. V.M. Weimar, G.W. Weimar, and R.I. Ceilley Estrogen-induced porphyria cutanea tarda complicating treatment of prostatic carcinoma J Urol 120 1978 643 644
7. G.H. Elder Porphyria cutanea tarda Semin Liver Dis 18 1998 67 75
8. G.H. Elder, S.G. Smith, C. Herrero, M. Lecha, J.M. Mascaro, and A.M. Muniesa Hepatoerythropoietic porphyria: a new uroporphyrinogen decarboxylase defect or homozygous porphyria cutanea tarda? Lancet 1 1981 916 919
9. M.J. Morán-Jiménez, C. Ged, M. Romana, R. Enriquez De Salamanca, A. Taieb, and G. Topi Uroporphyrinogen decarboxylase: complete human gene sequence and molecular study of three families with hepatoerythropoietic porphyria Am J Hum Genet 58 1996 712 721
10. C.F. Schanbacher, E.R. Vanness, M.S. Daoud, A. Tefferi, and W.P. Su Pseudoporphyria: a clinical and biochemical study of 20 patients Mayo Clin Proc 76 2001 488 492
11. J.D. Phillips, H.A. Bergonia, C.A. Reilly, M.R. Franklin, and J.P. Kushner A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda Proc Natl Acad Sci U S A 104 2007 5079 5084
12. A. Dubart, M.G. Mattei, N. Raich, D. Beaupain, P.H. Romeo, and J.F. Mattei Assignment of human uroporphyrinogen decarboxylase (URO-D) to the p34 band of chromosome 1 Hum Genet 73 1986 277 279
13. M. Romana, P. Le Boulch, and P.H. Roméo Rat uroporphyrinogen decarboxylase cDNA: nucleotide sequence and comparison to human uroporphyrinogen decarboxylase Nucleic Acids Res 15 1987 7211
14. F.G. Whitby, J.D. Phillips, J.P. Kushner, and C.P. Hill Crystal structure of human uroporphyrinogen decarboxylase EMBO J 17 1998 2463 2471
15. H. de Verneuil, B. Grandchamp, C. Beaumont, C. Picat, and Y. Nordmann Uroporphyrinogen decarboxylase structural mutant (Gly281 → Glu) in a case of porphyria Science 234 1986 732 734
16. L. Christiansen, C. Ged, I. Hombrados, J. Brons-Poulsen, A. Fontanellas, and H. de Verneuil Screening for mutations in the uroporphyrinogen decarboxylase gene using denaturing gradient gel electrophoresis. Identification and characterization of six novel mutations associated with familial PCT Hum Mutat 14 1999 222 232
17. M.D. Cappellini, F. Martinez di Montemuros, D. Tavazzi, S. Fargion, A. Pizzuti, and A. Comino Seven novel point mutations in the uroporphyrinogen decarboxylase (UROD) gene in patients with familial porphyria cutanea tarda (f-PCT) Hum Mutat 17 2001 350
18. M. Méndez, L. Sorkin, M.V. Rossetti, K.H. Astrin, A. Batlle, and V. Parera Familial porphyria cutanea tarda: characterization of seven novel uroporphyrinogen decarboxylase mutations and frequency of common hemochromatosis alleles Am J Hum Genet 63 1998 1363 1375
19. J.D. Phillips, T.L. Parker, H.L. Schubert, F.G. Whitby, C.P. Hill, and J.P. Kushner Functional consequences of naturally occurring mutations in human uroporphyrinogen decarboxylase Blood 98 2001 3179 3185
20. P. Poblete-Gutiérrez, M. Méndez, T. Wiederholt, H.F. Merk, A. Fontanellas, and C. Wolf The molecular basis of porphyria cutanea tarda in Chile: identification and functional characterization of mutations in the uroporphyrinogen decarboxylase gene Exp Dermatol 13 2004 372 379
21. C. Badenas, J. To-Figueras, J.D. Phillips, C.A. Warby, C. Muñoz, and C. Herrero Identification and characterization of novel uroporphyrinogen decarboxylase gene mutations in a large series of porphyria cutanea tarda patients and relatives Clin Genet 75 2009 346 353
22. M.E. Grossman, D.R. Bickers, M.B. Poh-Fitzpatrick, V.A. Deleo, and L.C. Harber Porphyria cutanea tarda. Clinical features and laboratory findings in 40 patients Am J Med 67 1979 277 286
23. C.A. Louis, S.G. Wood, H.S. Walton, P.R. Sinclair, and J.F. Sinclair Mechanism of the synergistic induction of CYP2H by isopentanol plus ethanol: comparison to glutethimide and relation to induction of 5-aminolevulinate synthase Arch Biochem Biophys 360 1998 239 247
24. A. Sánchez Rodríguez, D. Pérez Sandoval, J.J. Cruz Hernández, J. Rico Sánchez, and A. Juanes González Erythrocyte levels of the enzyme ALA-dehydrase in various kinds and stages of liver disease Rev Clin Esp 168 1983 87 90
25. K.E. McColl, G.G. Thompson, M.R. Moore, and A. Goldberg Acute ethanol ingestion and haem biosynthesis in healthy subjects Eur J Clin Invest 10 1980 107 112
26. D.O. Hourihane, and D.G. Weir Suppression of erythropoiesis by alcohol Br Med J 1 1970 86 89
27. Z.J. Bulaj, J.D. Phillips, R.S. Ajioka, M.R. Franklin, L.M. Griffen, and D.J. Guinee Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda Blood 95 2000 1565 1571
28. J.P. Kushner, D.P. Steinmuller, and G.R. Lee The role of iron in the pathogenesis of porphyria cutanea tarda. II. Inhibition of uroporphyrinogen decarboxylase J Clin Invest 56 1975 661 667
29. E.S. Feldman, and B.R. Bacon Hepatic mitochondrial oxidative metabolism and lipid peroxidation in experimental hexachlorobenzene-induced porphyria with dietary carbonyl iron overload Hepatology 9 1989 686 692
30. G.D. Sweeny, K.G. Jones, F.M. Cole, D. Basford, and F. Krestynski Iron deficiency prevents liver toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin Science 204 1979 332 335
31. H.L. Bonkovsky Mechanism of iron potentiation of hepatic uroporphyria: studies in cultured chick embryo liver cells Hepatology 10 1989 354 364
32. J.D. Phillips, L.K. Jackson, M. Bunting, M.R. Franklin, K.R. Thomas, and J.E. Levy A mouse model of familial porphyria cutanea tarda Proc Natl Acad Sci U S A 98 2001 259 264
33. J.N. Feder, A. Gnirke, W. Thomas, Z. Tsuchihashi, D.A. Ruddy, and A. Basava A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis Nat Genet 13 1996 399 408
34. K. Hashimoto, M. Hirai, and Y. Kurosawa A gene outside the human MHC related to classical HLA class I genes Science 269 1995 693 695
35. G.H. Elder, and M. Worwood Mutations in the hemochromatosis gene, porphyria cutanea tarda, and iron overload Hepatology 27 1998 289 291
36. C. Mura, O. Raguenes, and C. Ferec HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis Blood 93 1999 2502 2505
37. J. Frank, P. Poblete-Gutiérrez, R. Weiskirchen, H.F. Merk, and F. Lammert Hemochromatosis gene sequence deviations in German patients with porphyria cutanea tarda Physiol Res 55 Suppl. 2 2006 S75 S83
38. J.J. Brady, H.A. Jackson, A.G. Roberts, R.R. Morgan, S.D. Whatley, and G.L. Rowlands Co-inheritance of mutations in the uroporphyrinogen decarboxylase and hemochromatosis genes accelerates the onset of porphyria cutanea tarda J Invest Dermatol 115 2000 868 874
39. J. Cruz-Rojo, A. Fontanellas, M.J. Morán-Jiménez, S. Navarro-Ordóñez, M. García-Bravo, and M. Méndez Precipitating/aggravating factors of porphyria cutanea tarda in Spanish patients Cell Mol Biol (Noisy-le-grand) 48 2002 845 852
40. Z.J. Bulaj, M.R. Franklin, J.D. Phillips, K.L. Miller, H.A. Bergonia, and R.S. Ajioka Transdermal estrogen replacement therapy in postmenopausal women previously treated for porphyria cutanea tarda J Lab Clin Med 136 2000 482 488
41. R.K. Ockner, and R. Schmid Acquired porphyria in man and rat due to hexachlorobenzene intoxication Nature 189 1961 499
42. D.J. Cripps, H.A. Peters, A. Gocmen, and I. Dogramici Porphyria turcica due to hexachlorobenzene: a 20 to 30 year follow-up study on 204 patients Br J Dermatol 111 1984 413 422
43. K.D. Courtney Hexachlorobenzene (HCB): a review Environ Res 20 1979 225 266
44. G.H. Elder, J.O. Evans, and S.A. Matlin The effect of the porphyrogenic compound, hexachlorobenzene, on the activity of hepatic uroporphyrinogen decarboxylase in the rat Clin Sci Mol Med 51 1976 71 80
45. P.R. Sinclair, W.J. Bement, R.W. Lambrecht, N. Gorman, and J.F. Sinclair Chlorinated biphenyls induce cytochrome P450IA2 and uroporphyrin accumulation in cultures of mouse hepatocytes Arch Biochem Biophys 281 1990 225 232
46. G.H. Elder, and D.M. Sheppard Immunoreactive uroporphyrinogen decarboxylase is unchanged in porphyria caused by TCDD and hexachlorobenzene Biochem Biophys Res Commun 109 1982 113 120
47. A.P. Poland, and E. Glover 2,3,7,8-Tetrachlorodibenzo-p-dioxin: a potent inducer of delta-aminolevulinic acid synthetase Science 179 1973 476 477
48. B.A. Schwetz, J.M. Norris, G.L. Sparschu, U.K. Rowe, P.J. Gehring, and J.L. Emerson Toxicology of chlorinated dibenzo-p-dioxins Environ Health Perspect 5 1973 87 99
49. K.G. Jones, and G.D. Sweeney Dependence of the porphyrogenic effect of 2,3,7,8-tetrachlorodibenzo(p)dioxin upon inheritance of aryl hydrocarbon hydroxylase responsiveness Toxicol Appl Pharmacol 53 1980 42 49
50. T.Y. Chuang, R. Brashear, and C. Lewis Porphyria cutanea tarda and hepatitis C virus. A case control study and meta-analysis of the literature J Amer Acad Dermatol 41 1999 31 36
51. S. Thunell, and P. Harper Porphyrins, porphyrin metabolism, porphyrias. III. Diagnosis, care and monitoring in porphyria cutanea tarda-suggestions for a handling programme Scand J Clin Lab Invest 60 2000 561 579
52. J.M. Cortés, H. Oliva, F.J. Paradinas, and C. Hernandez- Guío The pathology of the liver in porphyria cutanea tarda Histopathology 4 1980 471 485
53. J.P. Kushner, C.Q. Edwards, M.M. Dadone, and M.H. Skolnick Heterozygosity for HLA-linked hemochromatosis as a likely cause of the hepatic siderosis associated with sporadic porphyria cutanea tarda Gastroenterology 88 1985 1232 1238
54. D. Cassiman, J. Vannoote, R. Roelandts, L. Libbrecht, T. Roskams, and J. van den Oord Porphyria cutanea tarda and liver disease. A retrospective analysis of 17 cases from a single centre and review of the literature Acta Gastroenterol Belg 71 2008 237 242
55. H. de Verneuil, C. Beaumont, J.C. Deybach, Y. Nordmann, Z. Sfar, and R. Kastally Enzymatic and immunological studies of uroporphyrinogen decarboxylase in familial porphyria cutanea tarda and hepatoerythropoietic porphyria Am J Hum Genet 36 1984 613 622
56. J. McManus, D. Blake, and S. Ratnaike An assay of uroporphyrinogen decarboxylase in erythrocytes Clin Chem 34 1988 2355 2357
57. L. D'Alessandro, D. Griso, G. Biolcati, A. Macri, and G.C. Topi Incidence of hereditary porphyria cutanea tarda (PCT) in a sample of the Italian population Arch Dermatol Res 284 1992 212 214
58. M.O. Doss Enzyme deficiency of erythrocytes in human porphyria Gematol Transfuziol 37 1992 10 15
59. C.A. Ramsay, T.M. Coltart, S. Blunt, S.A. Pawsey, and F. Giannelli Prenatal diagnosis of Xeroderma pigmentosum. Report of the first successful case Lancet 2 1974 1109 1112
60. V. Kordac, R. Papezová, and M. Semrádová Chloroquine in the treatment of porphyria cutanea tarda N Engl J Med 296 1977 949
61. P.L. Scholnick, J. Epstein, and H.S. Marver The molecular basis of the action of chloroquine in porphyria cutanea tarda J Invest Dermatol 61 1973 226 232
62. U. Stolzel, E. Kostler, D. Schuppan, M. Richter, U. Wollina, and M.O. Doss Hemochromatosis (HFE) gene mutations and response to chloroquine in porphyria cutanea tarda Arch Dermatol 139 2003 309 313